HMP Global November 1, 2024
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting value-based care to improve patient outcomes and cost-effectiveness.
Transcript:
James Hamrick, MD, MPH: My name is Dr James Hamrick. I am a medical oncologist and Vice President of Clinical Oncology at Flatiron Health. I am thrilled to be attending the Clinical Pathways conference this year, because it’s a great collection of stakeholders from different places in the oncology ecosystem and the content up on the stage is excellent. We hear the perspectives that really matter most in terms of transforming care and standardizing care, and the networking is...